: A PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF DS-3201B IN SUBJECTS WITH LYMPHOMAS

Clinical Trial Grant

Duke Scholars

Principal Investigator Jie Wang Medicine, Hematological Malignancies

Administered By

Duke Cancer Institute

Awarded By

Daiichi Sankyo Inc

Start Date

April 28, 2021

End Date

April 30, 2026

Administered By

Duke Cancer Institute

Awarded By

Daiichi Sankyo Inc

Start Date

April 28, 2021

End Date

April 30, 2026